Dublin-based biotech startup providing an "AI biologist" platform that analyses biological, clinical, and experimental datasets to accelerate preclinical drug development by revealing interactions between genes, proteins, and metabolic pathways.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| €1.8 M | Oct, 2025 | seed |
Frequently Asked Questions
What industries does Meta-Flux operate in?
Meta-Flux operates in the following industries: biotechnology, artificial intelligence, drug discovery, preclinical research.
How much total funding has Meta-Flux raised?
Meta-Flux has raised a total of $1,800,000.
Who are the investors in Meta-Flux?
The investors in Meta-Flux are: Senior executives at Pfizer, Senior executives at Merck, Senior executives at Gilead Sciences, Technology leaders from Google, Technology leaders from Amazon, Technology leaders from Indeed, Fernando Ferrer, Senior director in R&D at Gilead Sciences (individual investor).